Stay updated with breaking news from Ichnos sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, today...
/PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, announced that...
Transgene’s Combined General Meeting of May 25, 2022 Strasbourg, France, May 25, 2022, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonth...
Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard
/PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, today announced the...
The roles of Chairman and Chief Executive Officer will be separated. Dr. Riva proposed as new independent Director and non-executive Chairman of the Board. With more than 30 years of experience
/PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing novel multispecific antibodies for the treatment of cancer using the...